We previously identified galectin 9- and PINCH-derived peptides that induced HLA-A*02-restricted CTLs, HLA-A*24-restricted CTLs, and HLA-A*33-restricted CTLs (28), respectively, all of which exhibited specific and highly cytotoxic activities toward RCC cells. The gene discussed is LIMS1; the disease is renal cell carcinoma.